About ▼ Careers Internship MedBlog Contact us

LOGIN REGISTER

Medindia » News » Drug News » Johnson & Johnson's Drug to be Recommended for Rheumatoid Arthritis as Well

Johnson & Johnson's Drug to be Recommended for Rheumatoid Arthritis as Well

by Kathy Jones on May 14 2011 7:31 PM

Johnson & Johnson

After recommending Johnson & Johnson's drug Simponi as a treatment for psoriatic arthritis, Britainï¿½s premier health agency, National Institute for Health and Clinical Excellence (NICE) on Friday said that the drug can also be used to treat rheumatoid arthritis.

NICE had rejected the use of Simponi in treating psoriatic arthritis back in October but reversed its decision back in March after J&J said that they will be offering the drug in 100mg dose as well.

NICE has said that the drug can now be used in combination with methotrexate to treat rheumatoid arthritis in adults but only when the patient does not respond to the conventional anti-rheumatic drugs.

However the health agency added that J&J should offer 100mg doses of the drug for the same price of 50mg if it wants the drug to be paid for by Britain's state health service.

Osteoarthritis - Causes, Symptoms, DIagnosis, Treatment, FAQs

Osteoarthritis - Causes, Symptoms, DIagnosis, Treatment, FAQs
Osteoarthritis is one of the commonest joint disorder and occurs as we age due to wear and tear of a joint. Osteoarthritis can affect any joint of the body.

Source-Medindia

Hip Replacement-Osteoarthritis-Post Operative Complications

Hip Replacement-Osteoarthritis-Post Operative Complications
Are you experiencing pain due to damaged hips? Travel abroad to get replacement surgery at affordable prices.

Recommended Readings

Stiff Joints

Stiff joints are a major problem for the elderly, as the joints tend to wear-and-tear with advancing age, giving rise to joint pain and inflammation. There are many natural remedies, and medical treatments available for stiff joints.

Bursitis

Bursitis is the inflammation of the bursa, which is a fluid-filled sac that reduces friction during joint movement.

Spinal Cord Injury

Spinal Cord Injury

Spinal cord injury is an injury to the spinal cord that results in temporary or permanent changes in its function.

COX - 2 Inhibitors

COX - 2 Inhibitors

What are COX–2 Inhibitors? Why are they safer compared to NSAIDs and which conditions are best treated by these drugs. Learn more about COX-2 inhibitors.

Oligoarthritis

Most parents when told that their child has arthritis find it hard to believe it, as arthritis is regarded an adult's disease.

Autoimmune Disorders

Autoimmune Disorders

Autoimmune disorders occur when the immune system fails to recognize the body as ‘self’ and attacks it.

Latest Drug News

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

US FDA Approval of N-803: Ray of Hope For Bladder Cancer Patients

The US FDA approves a immunotherapy drug, N-803, for BCG-unresponsive non-muscle invasive bladder cancer, suggested to be used in conjunction with BCG.

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

Resmetirom For MASH: Approved by US FDA, Increase in Partnerships

The increasing trend in strategic partnerships between innovator companies, and the US FDA approval for Rezdiffra has led to a boost in the development of medications for MASH.

Semaglutide: A Dominant Player for Patients With Heart Failure

Semaglutide: A Dominant Player for Patients With Heart Failure

Data provesSemaglutideefficacy in treatment of Type 2 diabetes, obesity, heart failure, and chronic kidney failure, it emerges as important therapy in metabolic syndrome.

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Physician's Lack Agreement – Patients Prefer Branded or Generic Drugs?

Generics are not widely used, despite cost advantage, due to a lack of information to patients and reluctance from physicians to prescribe generics - A Need to educate masses

Drug Resistant Melanoma Caused Due to Break in Genes!

Drug Resistant Melanoma Caused Due to Break in Genes!

Studies have led to discovery that drug-resistant melanomas are caused by breaks in the genes, thereby leading to emphasis on alternate targeted therapies to combat cancer.

Advertisement